The leaflet describes the latest clinical study conducted on 456 IBS volunteers, presented in october during the United European Gastroenterology virtual week. In this study, ibSium® confirmed its efficacy to alleviate abdominal pain and ...
BREATHE, PLAY, LAUGH, BE FREE, RELAX, ENJOY, LIVE … these are just some of the words you will find in the new engaging video signed Gnosis by Lesaffre. Discover it to further understand our vision and mission...
Discover in this WEBINAR " Active Folate vs Folic Acid: what's the big debate around folate? Discover Quatrefolic®" all the recent market and scientific updates about folate, with our expert Luca Tiano...
Gnosis by Lesaffre is preparing for the next virtual event: Fi Europe CONNECT 2020. We are pleased to invite you at this event, taking place online from November 23rd to December 4th, where we will introduce something more about the innovations we are implementing. As an anticipation,...
S-adenosyl-methionine, often known as SAMe, is one of the most researched and proven nootropic compounds, supporting healthy mood and promoting overall brain health. While the brain-stimulating effect of SAMe supplementation is well known, the quality requirements this nutritional ingredient should have to ensure clinical efficacy are...
This year's IPA World Congress + Probiota Americas Digital Summit 2020 will explore topics about next generation probiotics to the latest developments in the gut-brain axis, how modulation of the microbiome may impact health and wellbeing. LifeinU™ BSCU1 is a unique solution in terms of stable...
Gnosis by Lesaffre is striving to create a world that moves better, digests better, ages better, feels better, and, ultimately, lives better thanks to microorganisms and biotransformation. Earlier this month, Gnosis by Lesaffre unveiled its new, fully integrated brand and business strategy to help make...
After many weeks of work, tomorrow October 7th Gnosis by Lesaffre will officially reveal its new brand identity. A webinar of about 30 minutes, where the General Manager – Marc Philouze - and other leading people who have contributed to the project, will reveal the new...
Today, Monday October 5th, the CPhI Festival of Pharma starts. CPhI is the most anticipated European pharma event and this year it will run virtually from October 5 to 16. Gnosis by Lesaffre will not miss its yearly appointment! During these two weeks our team of 10 experts will be available to...
You might have noticed that the past two years have been full of exciting changes for Gnosis by Lesaffre. Recently we have started to unveil our new brand identity through our News, Social Media and Advertising, and very soon the new Corporate website will be...
WCO-IOF-ESCEO poster presentation highlights implications of correcting vitamin K2 deficiency on children’s bone health....
You might have noticed that the past two years have been full of exciting changes for Gnosis by Lesaffre. Recently we have started to unveil our new brand identity through our News, Social Media and Advertising, and very soon the new Corporate website will be...
CORPORATE HEADQUARTERS
101 rue de Menin
59700 Marcq-en-Baroeul
France
We are a proud business unit of Lesaffre.
Enter your contact information below to be added to our monthly email newsletter, keeping you up-to-date with the latest information from Gnosis by Lesaffre
Get in the conversation – follow us on social media!
The information provided here is, to the best of our knowledge, true and accurate. However, our products must only be used in compliance with local laws and regulations. We cannot guarantee the freedom of use for every intended application or country. These statements may not have been evaluated by your local Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease. A healthy, balanced and diversified diet should fulfill all nutritional needs.
©2020 Gnosis by Lesaffre | Legal Notices
